Crossmark Global Holdings, Inc. Vertex Pharmaceuticals Inc Transaction History
Crossmark Global Holdings, Inc.
- $5.23 Billion
- Q2 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 6,164 shares of VRTX stock, worth $2.9 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,164
Previous 6,198
0.55%
Holding current value
$2.9 Million
Previous $2.59 Million
11.54%
% of portfolio
0.06%
Previous 0.05%
Shares
29 transactions
Others Institutions Holding VRTX
# of Institutions
1,708Shares Held
226MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$12.5 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.51 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.01 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...